"10.1371_journal.pone.0032240","plos one","2012-03-23T00:00:00Z","Walter Maetzler; Martina Mancini; Inga Liepelt-Scarfone; Katharina MÃ¼ller; Clemens Becker; Rob C van Lummel; Erik Ainsworth; Markus Hobert; Johannes Streffer; Daniela Berg; Lorenzo Chiari","Center of Neurology, Hertie Institute for Clinical Brain Research, Department for Neurodegenerative Diseases, University of TÃ¼bingen, TÃ¼bingen, Germany; DZNE, German Center for Neurodegenerative Diseases, TÃ¼bingen, Germany; Department of Geriatric Rehabilitation, Robert-Bosch-Hospital, Stuttgart, Germany; Department of Electronics, Computer Science and Systems, University of Bologna, Bologna, Italy; McRoberts, The Hague, The Netherlands; Janssen Research and Development, Janssen â€ Pharmaceutical Companies of Johnson & Johnson, Beerse, Belgium","Conceived and designed the experiments: WM IL RCL CB DB LC. Performed the experiments: WM IL KM MH. Analyzed the data: WM MM IL EA LC. Contributed reagents/materials/analysis tools: MM RCL EA DB LC. Wrote the paper: WM MM DB LC JS.","Rob C van Lummel and Erik Ainsworth are employed by the McRoberts B.V. This company is manufacturer of the DynaPort which was used for the measurements presented in this paper. Johannes Streffer is employed by Johnson and Johnson which sponsored the PMPP study (Progression markers in the suspected prediagnostic phase of Parkinsons disease). The funding of the PMPP study is pre-competitive. All these aspects do not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","03","Walter Maetzler","WM",11,TRUE,6,4,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
